Kyowa Kirin Co. Ltd

PINK:KYKOF USA Drug Manufacturers - Specialty & Generic
Market Cap
$7.72 Billion
Market Cap Rank
#3613 Global
#2348 in USA
Share Price
$14.75
Change (1 day)
+0.00%
52-Week Range
$13.65 - $14.75
All Time High
$32.97
About

Kyowa Kirin Co., Ltd. engages in the research, development, manufacture, import/export, and market of pharmaceuticals products worldwide. The company offers Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; POTELIGEO for the treatment of cutaneous T-cell lymphoma; Nouriast/Nourianz, an adenosine A2A receptor antagonist; G-LASTA, a… Read more

Kyowa Kirin Co. Ltd (KYKOF) - Total Liabilities

Latest total liabilities as of December 2025: $214.72 Billion USD

Based on the latest financial reports, Kyowa Kirin Co. Ltd (KYKOF) has total liabilities worth $214.72 Billion USD as of December 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Kyowa Kirin Co. Ltd - Total Liabilities Trend (1999–2025)

This chart illustrates how Kyowa Kirin Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Kyowa Kirin Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Kyowa Kirin Co. Ltd ranked by their total liabilities.

Liability Composition Analysis (1999–2025)

This chart breaks down Kyowa Kirin Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.72 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.24 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.19 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kyowa Kirin Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kyowa Kirin Co. Ltd (1999–2025)

The table below shows the annual total liabilities of Kyowa Kirin Co. Ltd from 1999 to 2025.

Year Total Liabilities Change
2025-12-31 $214.72 Billion -0.85%
2024-12-31 $216.55 Billion +14.26%
2023-12-31 $189.52 Billion +7.04%
2022-12-31 $177.06 Billion -4.14%
2021-12-31 $184.71 Billion +79.51%
2020-12-31 $102.89 Billion -3.12%
2019-12-31 $106.20 Billion +14.99%
2018-12-31 $92.36 Billion +0.10%
2017-12-31 $92.27 Billion -4.31%
2016-12-31 $96.42 Billion -8.96%
2015-12-31 $105.91 Billion -6.91%
2014-12-31 $113.77 Billion -8.14%
2013-12-31 $123.84 Billion +0.32%
2012-12-31 $123.44 Billion +3.87%
2011-12-31 $118.85 Billion -21.22%
2010-12-31 $150.87 Billion -2.62%
2009-12-31 $154.93 Billion +12.82%
2007-12-31 $137.32 Billion +1.88%
2006-12-31 $134.79 Billion +6.23%
2005-12-31 $126.89 Billion -7.78%
2004-12-31 $137.59 Billion +2.17%
2003-12-31 $134.67 Billion -9.18%
2002-12-31 $148.27 Billion -31.68%
2001-12-31 $217.01 Billion -7.40%
2000-12-31 $234.35 Billion -0.24%
1999-12-31 $234.92 Billion --